GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lonza Group Ltd (OTCPK:LZAGY) » Definitions » Price-to-Operating-Cash-Flow

Lonza Group (Lonza Group) Price-to-Operating-Cash-Flow

: 25.53 (As of Today)
View and export this data going back to 2008. Start your Free Trial

As of today (2024-04-19), Lonza Group's share price is $55.15. Lonza Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $2.16. Hence, Lonza Group's Price-to-Operating-Cash-Flow Ratio for today is 25.53.

The historical rank and industry rank for Lonza Group's Price-to-Operating-Cash-Flow or its related term are showing as below:

LZAGY' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 4.45   Med: 21.67   Max: 51.42
Current: 26.84

During the past 13 years, Lonza Group's highest Price-to-Operating-Cash-Flow Ratio was 51.42. The lowest was 4.45. And the median was 21.67.

LZAGY's Price-to-Operating-Cash-Flow is ranked worse than
68.1% of 116 companies
in the Medical Diagnostics & Research industry
Industry Median: 18.2 vs LZAGY: 26.84

Lonza Group's Cash Flow from Operations per share for the six months ended in Dec. 2023 was $1.61. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $2.16.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Lonza Group was 37.30% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 7.60% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 4.40% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 6.00% per year.

During the past 13 years, Lonza Group's highest 3-Year average Operating Cash Flow per Share Growth Rate was 48.10% per year. The lowest was -26.30% per year. And the median was 4.10% per year.

Lonza Group Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Lonza Group's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lonza Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.71 37.61 46.62 33.03 18.78

Lonza Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Operating-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.62 - 33.03 - 18.78
Competitive Comparison

For the Diagnostics & Research subindustry, Lonza Group's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lonza Group Price-to-Operating-Cash-Flow Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Lonza Group's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Lonza Group's Price-to-Operating-Cash-Flow falls into.


Lonza Group Price-to-Operating-Cash-Flow Calculation

Lonza Group's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=55.15/2.16
=25.53

Lonza Group's Share Price of today is $55.15.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lonza Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $2.16.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Lonza Group Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Lonza Group's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Lonza Group (Lonza Group) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lonza Group Ltd (OTCPK:LZAGY) » Definitions » Price-to-Operating-Cash-Flow
Comparable Companies
XSWX:EMMN XSWX:ARYN XSWX:ORON XSWX:BARN XSWX:BELL XSWX:GMI XSWX:HOCN XSWX:GALD TSE:2309 TMO DHR IQV IDXX A MTD ICLR ILMN WAT SHSE:603259 LH
Traded in Other Exchanges
LZAGF:USA LONN:Mexico LONNz:UK LO3A:Germany LONNE:Switzerland LONN:Switzerland
Address
Muenchensteinerstrasse 38, Basel, CHE, CH-4002
Website
https://www.lonza.com
Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.